Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease
Open accessIntegrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In men with coronary artery disease, flow-mediated vasodilatation is observed after 12 weeks of testosterone treatment.
“In men with coronary artery disease flow-mediated vasodilatation was observed after 12 weeks (61).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [61]
Cites
Lerner, D., & Kannel, W. B. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90155-9 · Cited by 1,730 · see citing works
Effects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768 · see citing works
Effects of testosterone supplementation in the aging male.
Tenover, J. S. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400877 · Cited by 702 · see citing works
Increased Estrogen Production in Obese Men*
SCHNEIDER, G. T., Kirschner, M. A., Berkowitz, R. D., & Ertel, N. H. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-4-633 · Cited by 507 · see citing works
Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study
Morley, J. E., Perry, H. M., Kaiser, F. E., Kraenzle, D., Jensen, J., Houston, K., Mattammal, M. B., & Perry, H. M. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb02049.x · Cited by 462 · see citing works
Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease
Webb, C. M., McNeill, J. G., Hayward, C. S., de Zeigler, D., & Collins, P. (1999) · Circulation · doi:10.1161/01.cir.100.16.1690 · Cited by 451 · see citing works
The association of hypotestosteronemia with coronary artery disease in men.
Phillips, G. B., Pinkernell, B. H., & Jing, T. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.701 · Cited by 400 · see citing works
English, K. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1873 · Cited by 350 · see citing works
Testosterone Substitution Normalizes Elevated Serum Leptin Levels in Hypogonadal Men
Jockenhövel, F., Blum, W. F., Vogel, E., Englaro, P., Müller-Wieland, D., Reinwein, D., Rascher, W., & Krone, W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4174 · Cited by 261 · see citing works
Natural Androgens Inhibit Male Atherosclerosis
Alexandersen, P., Haarbo, J., Byrjalsen, I., Lawaetz, H., & Christiansen, C. (1999) · Circulation Research · doi:10.1161/01.res.84.7.813 · Cited by 251 · see citing works
Effect of acute testosterone on myocardial ischemia in men with coronary artery disease
Webb, C. M., Adamson, D. L., de Zeigler, D., & Collins, P. D. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00880-7 · Cited by 242 · see citing works
Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women
Guetta, V., & Cannon, R. O. (1996) · Circulation · doi:10.1161/01.cir.93.10.1928 · Cited by 202 · see citing works
Effect of testosterone cypionate on postexercise ST segment depression.
Jaffe, M. D. (1977) · Heart · doi:10.1136/hrt.39.11.1217 · Cited by 155 · see citing works
Haffner, S. M., Kushwaha, R. S., Foster, D. M., Applebaum-Bowden, D. M., & Hazzard, W. R. (1983) · Metabolism · doi:10.1016/0026-0495(83)90052-5 · Cited by 154 · see citing works
Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease
Ong, P. J. L., Patrizi, G., Chong, W. C. F., Webb, C. M., Hayward, C., & Collins, P. L. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00630-x · Cited by 141 · see citing works
TESTOSTERONE PROPIONATE THERAPY IN ONE HUNDRED CASES OF ANGINA PECTORIS
Lesser, M. A. (1946) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-6-8-549 · Cited by 87 · see citing works
Testosterone enanthate at a dose of 200 mg/week decreases HDL‐cholesterol levels in healthy men
Meriggiola, M. C., Marcovina, S. M., Paulsen, C. A., & Bremner, W. J. (1995) · International Journal of Andrology · doi:10.1111/ijan.1995.18.5.237 · Cited by 77 · see citing works
Testosterone Propionate in the Treatment of Angina Pectoris
HAMM, L. (1942) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-2-5-325 · Cited by 70 · see citing works
Travia, D., Tosi, F., Negri, C., Faccini, G., Moghetti, P., & Muggeo, M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883839 · Cited by 52 · see citing works
The Therapeutic Value of Testosterone Propionate in Angina Pectoris
Levine, S. A., & LIKOFF, W. B. (1943) · New England Journal of Medicine · doi:10.1056/nejm194311182292102 · Cited by 44 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Aversa, A., Isidori, A. M., Spera, G., Lenzi, A., & Fabbri, A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01764.x · Cited by 343 · see citing works
Onset of effects of testosterone treatment and time span until maximum effects are achieved
Saad, F., Aversa, A., Isidori, A. M., Zafalon, L., Zitzmann, M., & Gooren, L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0221 · Cited by 232 · see citing works
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221 · see citing works
Low Testosterone Level Is an Independent Determinant of Endothelial Dysfunction in Men
AKISHITA, M., HASHIMOTO, M., OHIKE, Y., OGAWA, S., IIJIMA, K., ETO, M., & OUCHI, Y. (2007) · Hypertension Research · doi:10.1291/hypres.30.1029 · Cited by 179 · see citing works
Jones, R. D., Pugh, P. J., Jones, T. H., & Channer, K. S. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705141 · Cited by 153 · see citing works
Treatment of Men for “Low Testosterone”: A Systematic Review
Huo, S., Scialli, A. R., McGarvey, S., Hill, E., Tügertimur, B., Hogenmiller, A., Hirsch, A. I., & Fugh-Berman, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162480 · Cited by 97 · see citing works
Effect of testosterone on <i>ex vivo</i> vascular reactivity in man
Malkin, C. J., Jones, R. D., Jones, T. H., & Channer, K. S. (2006) · Clinical Science · doi:10.1042/cs20050354 · Cited by 81 · see citing works
- Authors
- Kang, S.-M., Jang, Y., Kim, J. I.-Y., Chung, N., Cho, S.-Y., Chae, J. S., & Lee, J.-H. O.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Jang, Yangsoo
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 89
- Issue
- 7
- Pages
- 862-864
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2162632293
- Cited by
- 105
- References
- 20
- Citations by year
- 2024: 2 · 2023: 3 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 8 · 2013: 11 · 2012: 7
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- testosterone, coronary artery disease, testosterone replacement therapy, hypogonadism, angina pectoris, endothelial function, nitric oxide, nitric oxide synthase, nitric oxide synthase inhibition, nitric oxide donors, angiotensin II, angiotensin II receptor, angiotensin-converting enzyme
- MeSH terms
- Administration, Oral, Aged, Brachial Artery, Coronary Disease, Endothelium, Vascular, Female, Humans, Lipids, Male, Middle Aged, Testosterone, Vasodilation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review